General Resources / Legal Resources / Medical Resources / Briefing Papers / State Activity    
Hospital Closures / Preventable Tragedies / Press Room / Search Our Site / Home

Insight and its Related Factors in Chronic Schizophrenic Patients: A preliminary Study.

 

Takai A; Uematsu M; Ueki H, Sone K and Kaiya Hisanobu.

European Journal of Psychiatry, 6:159-170, 1992.

RELEVANCE FOR EARLY INTERVENTION

Lack of insight into having an illness, defined by a single item on the Present State Examination, was correlated with structural brain abnormalities. Specifically, patients with poor insight into having an illness had increased ventricular brain rations. Ventricular enlargement of the third ventricle was most strongly correlated with poor insight. Meanwhile, IQ was not found to be significantly associated with insight suggesting that the brain dysfunction underlying this deficit in self awareness may be relatively specific rather than a consequence of a general decline in cognitive function. This study is the first to show an association between structural brain abnormalities and lower levels of insight in patients with chronic schizophrenia. It adds to the growing body of literature that suggests that poor insight in this disorder is a consequence of a mental defect.


General Resources / Legal Resources / Medical Resources / Briefing Papers / State Activity   
Hospital Closures / Preventable Tragedies / Press Room / Search Our Site / Home

FootnoteImage2.jpg (1088 bytes)
Treatment Advocacy Center

The contents of all material available on the Center's website are copyrighted by the Treatment Advocacy Center unless otherwise indicated.  All rights reserved and content may be reproduced, downloaded, disseminated, or transferred, for single use, or by nonprofit organizations for educational purposes only, if correct attribution is made to the Treatment Advocacy Center.  Please feel free to call with questions on mental illness, treatment laws or the benefits of medication compliance at 703.294.6001 or send questions via email to [email protected].    Write to us at:  The Treatment Advocacy Center; 3300 N. Fairfax Drive; Suite 220; Arlington, VA  22201.  Technical comments on the Center's website (www.psychlaws.org) can be sent to [email protected]. The Treatment Advocacy Center is an I.R.C. � 501(c)(3) tax-exempt corporation.  Donations are appreciated and are eligible for the charitable contribution deduction under the provisions of I.R.C. � 170.